Nerlynx 40 mg, Filmtabletten

7680672930015 CH-67293 Filmtabletten

Associated product:

NERLYNX cpr pell 40 mg 180 pce
Nerlynx 40 mg, Filmtabletten
Nerlynx 40 mg, Filmtabletten
Nerlynx 40 mg, Filmtabletten
1 / 3
google

Article details

Package size
180
Selling units
180
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/02/2025
Summary of Product Characteristics
Français
05/02/2025
Patient information leaflet
Allemand
30/01/2025
Patient information leaflet
Français
30/01/2025
Patient information leaflet
Italien
30/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Authorization holder

Pierre Fabre Pharma SA

4052 Basel

Authorization information

Swissmedic authorization number
67293
Drug name
Nerlynx, Filmtabletten
Galenic form
FILM
ATC Code
L01EH02
Authorization status
Z
Dispensing category
A
First authorization
20/03/2020
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Brustkrebs

Package details

Description (FR)
NERLYNX cpr pell 40 mg 180 pce
Description (DE)
NERLYNX Filmtabl 40 mg 180 Stk
Market launch
20/03/2020
Narcotic (BTM)
No